|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:drug
antidepressant
|
|
gptkbp:abusePotential
|
high (when misused)
|
|
gptkbp:ATCCode
|
N06AX14
|
|
gptkbp:CASNumber
|
66981-73-5
|
|
gptkbp:chemicalFormula
|
C21H25ClN2O4S
|
|
gptkbp:compatibleWith
|
gptkb:United_States_Food_and_Drug_Administration
|
|
gptkbp:discoveredBy
|
gptkb:French_Society_of_Medical_Research
|
|
gptkbp:discoveredIn
|
1960s
|
|
gptkbp:eliminationHalfLife
|
2.5 hours
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:hasSMILES
|
CC1=CC2=C(C=C1)SC3=CC=CC=C3N(C2=O)CCCCCCC(=O)O.Cl
|
|
gptkbp:hasUNII
|
81R68T2A2S
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Tianeptine
|
|
gptkbp:IUPACName
|
7-[(3-chloro-6-methyl-5,5-dioxo-6,11-dihydro-5H-dibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid
|
|
gptkbp:legalStatus
|
prescription only (in some countries)
controlled substance (in some countries)
|
|
gptkbp:marketedAs
|
gptkb:Coaxil
gptkb:Stablon
gptkb:Tatinol
|
|
gptkbp:mechanismOfAction
|
mu-opioid receptor agonist
atypical antidepressant
modulates glutamate receptors
|
|
gptkbp:meltingPoint
|
180-184°C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
436.96 g/mol
|
|
gptkbp:overdoseSymptoms
|
death
coma
respiratory depression
|
|
gptkbp:PubChem_CID
|
gptkb:DB09052
gptkb:CHEMBL178
5487
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
abdominal pain
constipation
drowsiness
addiction potential
|
|
gptkbp:soldOnlineAs
|
research chemical
nootropic
|
|
gptkbp:usedFor
|
treatment of anxiety
treatment of major depressive disorder
treatment of irritable bowel syndrome
|
|
gptkbp:bfsParent
|
gptkb:Antidepressants
|
|
gptkbp:bfsLayer
|
6
|